ESR1 and cancer: In physiological conditions (complete serum) and at the concentration of 10 μM, ERα17p triggers membrane-initiated pro-apoptotic events, in both ERα-positive and -negative breast cancer cell lines with, however, a preference for ERα-positive cancer cells21.